News & Updates
Filter by Specialty:
ADHD medication use carries no excess risk of cardiovascular diseases
Users of attention-deficit/hyperactivity disorder (ADHD) medications across age groups do not appear to be at increased risk of cardiovascular diseases (CVDs), although a modest risk increase of cardiac arrest or tachyarrhythmias could not be ruled out, according to the results of a meta-analysis.
ADHD medication use carries no excess risk of cardiovascular diseases
02 Dec 2022Maximum home BP predicts cardiovascular outcomes in T2D patients
In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.
Maximum home BP predicts cardiovascular outcomes in T2D patients
02 Dec 2022IV iron cuts risk of HF rehospitalization, CV death in ambulatory HFrEF patients
In a broad range of patients with HFrEF* and iron deficiency, the administration of IV ferric derisomaltose (FDI) was associated with a lower risk of recurrent hospitalization for heart failure (HHF) and cardiovascular (CV) death compared with standard of care (SoC), findings from the IRONMAN** trial have shown.
IV iron cuts risk of HF rehospitalization, CV death in ambulatory HFrEF patients
02 Dec 20223-month rivaroxaban use safe, effective in isolated DVT
Treatment with rivaroxaban for 3 months leads to a safe and successful reduction of recurrent venous thromboembolism (VTE) risk compared to treatment for 6 weeks in patients with isolated distal deep vein thrombosis (DVT), a study has shown.
3-month rivaroxaban use safe, effective in isolated DVT
01 Dec 20221-year isometric exercise training improves BP management
Isometric exercise training (IET) appears to be a good long-term intervention in managing resting blood pressure (BP), reports a recent study. IET delivers clinically important, chronic BP adaptations in patients at risk of hypertension.
1-year isometric exercise training improves BP management
01 Dec 2022Chinese herbal med cuts MACCE in STEMI, but questions remain
Tongxinluo, added to guideline-directed therapy, improves outcomes in patients with acute ST-segment elevation myocardial infarction (STEMI) in the large, multicentre CTS-AMI* study. But experts are clamouring for more evidence of efficacy.
Chinese herbal med cuts MACCE in STEMI, but questions remain
01 Dec 2022Intensive antihypertensive therapy vital in kids with arterial hypertension after CoA repair
Close blood pressure (BP) monitoring and more intensive and combined antihypertensive therapy are needed when there is a high prevalence of uncontrolled arterial hypertension (AH) despite the successful coarctation of the aorta (CoA) correction and use of relatively low doses of antihypertensive drugs, suggests a recent study.